CIK: 1854586 - Address: C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Ste. 400, South San Francisco, CA 94080
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/19/23 16:07
4/18/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOChief MeS-176.570-3-2141D
1/11/23 16:05
1/10/23
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOChief MeS-415.240-8-5143D
4/21/22 16:04
4/19/22
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOChief MeS-14435.370-4-3151D
1/13/22 16:05
1/11/22
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOSVP ClinS-19248.510-4-3122D
12/13/21 17:53
12/10/21
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOSVP ClinM.d12216.32086126D
12/13/21 17:53
12/10/21
FATEFate Therapeutics IncHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOSVP ClinS.d-38651.460-8-6126D
4/20/21 16:00
4/16/21
FATEFate Therapeutics IncDEHealthBioPrdBiological Products, (No DiagChu Yu-WayeCAOSVP ClinS-27383.300-3-565D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact